Want to see JP:6190 full AI Analyst Report?
PhoenixBio Co., Ltd. (6190) Income Statement
PhoenixBio Co., Ltd. Income Statement
Last quarter (Q4 2025), PhoenixBio Co., Ltd.'s total revenue was $364.82M, a decrease of 8.35% from the same quarter last year. In Q4, PhoenixBio Co., Ltd.'s net income was $32.01M. See PhoenixBio Co., Ltd.’s key income statements, including revenue, expenses, profit, and income.
| Income Statement | Mar 26 | Mar 25 | Mar 24 | Mar 23 | Mar 22 |
|---|---|---|---|---|---|
| $ 1.57B | $ 1.54B | $ 1.72B | $ 2.12B | $ 1.32B | |
| $ 1.19B | $ 1.11B | $ 1.20B | $ 1.56B | $ 727.79M | |
| $ 1.11B | $ 1.24B | $ 1.18B | $ 1.05B | $ 895.41M | |
| Depreciation and Amortization | $ 33.75M | $ 28.20M | $ 25.23M | $ 23.70M | $ 86.24M |
| $ 116.52M | $ -396.12M | $ 87.94M | $ 537.42M | $ -305.81M | |
| $ 82.77M | $ -135.17M | $ 11.06M | $ 508.45M | $ -167.62M | |
| $ 48.67M | $ -294.39M | $ 48.72M | $ 2.20M | $ -225.38M | |
| $ 131.44M | $ -429.56M | $ 59.78M | $ 510.64M | $ -393.00M | |
| $ 125.23M | $ -445.65M | $ 26.38M | $ 493.33M | $ -387.97M | |
| Per Share Metrics | |||||
| Basic EPS | $ 30.81 | $ -110.18 | $ 6.98 | $ 145.23 | $ -117.50 |
| Diluted EPS | $ 30.81 | $ -110.18 | $ 6.98 | $ 91.31 | $ -117.50 |
| Weighted Average Shares Outstanding | 4.06M | 4.04M | 3.78M | 3.40M | 3.30M |
| Weighted Average Shares Outstanding (Diluted) | 4.06M | 4.04M | 3.78M | 5.40M | 3.30M |
Currency in JPY
